BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 17574961)

  • 1. The origin of chromosome imbalances in neuroblastoma.
    Stallings RL; Yoon K; Kwek S; Ko D
    Cancer Genet Cytogenet; 2007 Jul; 176(1):28-34. PubMed ID: 17574961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of chromosome breakpoints in neuroblastoma at sub-kilobase resolution using fine-tiling oligonucleotide array CGH.
    Selzer RR; Richmond TA; Pofahl NJ; Green RD; Eis PS; Nair P; Brothman AR; Stallings RL
    Genes Chromosomes Cancer; 2005 Nov; 44(3):305-19. PubMed ID: 16075461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Origin and functional significance of large-scale chromosomal imbalances in neuroblastoma.
    Stallings RL
    Cytogenet Genome Res; 2007; 118(2-4):110-5. PubMed ID: 18000361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translocation and gross deletion breakpoints in human inherited disease and cancer I: Nucleotide composition and recombination-associated motifs.
    Abeysinghe SS; Chuzhanova N; Krawczak M; Ball EV; Cooper DN
    Hum Mutat; 2003 Sep; 22(3):229-44. PubMed ID: 12938088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligonucleotide array-based comparative genomic hybridization (aCGH) of 90 neuroblastomas reveals aberration patterns closely associated with relapse pattern and outcome.
    Spitz R; Oberthuer A; Zapatka M; Brors B; Hero B; Ernestus K; Oestreich J; Fischer M; Simon T; Berthold F
    Genes Chromosomes Cancer; 2006 Dec; 45(12):1130-42. PubMed ID: 16958102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and characterization of DNA imbalances in neuroblastoma by high-resolution oligonucleotide array comparative genomic hybridization.
    Scaruffi P; Coco S; Cifuentes F; Albino D; Nair M; Defferrari R; Mazzocco K; Tonini GP
    Cancer Genet Cytogenet; 2007 Aug; 177(1):20-9. PubMed ID: 17693187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-resolution analysis of chromosomal breakpoints and genomic instability identifies PTPRD as a candidate tumor suppressor gene in neuroblastoma.
    Stallings RL; Nair P; Maris JM; Catchpoole D; McDermott M; O'Meara A; Breatnach F
    Cancer Res; 2006 Apr; 66(7):3673-80. PubMed ID: 16585193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stepwise occurrence of a complex unbalanced translocation in neuroblastoma leading to insertion of a telomere sequence and late chromosome 17q gain.
    Schleiermacher G; Bourdeaut F; Combaret V; Picrron G; Raynal V; Aurias A; Ribeiro A; Janoueix-Lerosey I; Delattre O
    Oncogene; 2005 May; 24(20):3377-84. PubMed ID: 15735707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isochromosome breakpoints on 17p in medulloblastoma are flanked by different classes of DNA sequence repeats.
    Mendrzyk F; Korshunov A; Toedt G; Schwarz F; Korn B; Joos S; Hochhaus A; Schoch C; Lichter P; Radlwimmer B
    Genes Chromosomes Cancer; 2006 Apr; 45(4):401-10. PubMed ID: 16419060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a complex genomic alteration on chromosome 2p that leads to four alternatively spliced fusion transcripts in the neuroblastoma cell lines IMR-5, IMR-5/75 and IMR-32.
    Oberthuer A; Skowron M; Spitz R; Kahlert Y; Westermann F; Mehler K; Berthold F; Fischer M
    Gene; 2005 Dec; 363():41-50. PubMed ID: 16216448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breakpoint position on 17q identifies the most aggressive neuroblastoma tumors.
    Ɓastowska M; Cotterill S; Bown N; Cullinane C; Variend S; Lunec J; Strachan T; Pearson AD; Jackson MS
    Genes Chromosomes Cancer; 2002 Aug; 34(4):428-36. PubMed ID: 12112532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Structural organization of the human genome: distribution of nucleotides, Alu-repeats and exons in chromosomes 21 and 22].
    Blinov VM; Denisov SI; Saraev DV; Shvetsov DV; Uvarov DL; Oparina NIu; Sandakhchiev LS; Kiselev LL
    Mol Biol (Mosk); 2001; 35(6):1032-8. PubMed ID: 11771127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular cytogenetic definition of 17q translocation breakpoints in neuroblastoma.
    Lastowska M; Van Roy N; Bown N; Speleman F; Roberts P; Lunec J; Strachan T; Pearson AD; Jackson MS
    Med Pediatr Oncol; 2001 Jan; 36(1):20-3. PubMed ID: 11464884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular processes of chromosome 9p21 deletions in human cancers.
    Sasaki S; Kitagawa Y; Sekido Y; Minna JD; Kuwano H; Yokota J; Kohno T
    Oncogene; 2003 Jun; 22(24):3792-8. PubMed ID: 12802286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of Alu repeat clusters as mediators of recurrent chromosomal aberrations in tumors.
    Kolomietz E; Meyn MS; Pandita A; Squire JA
    Genes Chromosomes Cancer; 2002 Oct; 35(2):97-112. PubMed ID: 12203773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ArrayCGH-based classification of neuroblastoma into genomic subgroups.
    Michels E; Vandesompele J; De Preter K; Hoebeeck J; Vermeulen J; Schramm A; Molenaar JJ; Menten B; Marques B; Stallings RL; Combaret V; Devalck C; De Paepe A; Versteeg R; Eggert A; Laureys G; Van Roy N; Speleman F
    Genes Chromosomes Cancer; 2007 Dec; 46(12):1098-108. PubMed ID: 17823929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rare pathogenic microdeletions and tandem duplications are microhomology-mediated and stimulated by local genomic architecture.
    Vissers LE; Bhatt SS; Janssen IM; Xia Z; Lalani SR; Pfundt R; Derwinska K; de Vries BB; Gilissen C; Hoischen A; Nesteruk M; Wisniowiecka-Kowalnik B; Smyk M; Brunner HG; Cheung SW; van Kessel AG; Veltman JA; Stankiewicz P
    Hum Mol Genet; 2009 Oct; 18(19):3579-93. PubMed ID: 19578123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping Drosophila genomic aberration breakpoints with comparative genome hybridization on microarrays.
    Erickson JN; Spana EP
    Methods Enzymol; 2006; 410():377-86. PubMed ID: 16938561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosome 3p microsatellite allelotyping in neuroblastoma: a report on the technical hurdles.
    Hoebeeck J; De Wilde B; Michels E; Combaret V; Yigit N; De Smet E; Van Roy N; Stanbridge E; Ru N; Laureys G; De Paepe A; Speleman F; Vandesompele J
    Cancer Invest; 2009 Oct; 27(8):857-68. PubMed ID: 19544108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosome abnormalities in ovarian adenocarcinoma: II. Prognostic impact of nonrandom chromosome abnormalities in 244 cases.
    Taetle R; Aickin M; Panda L; Emerson J; Roe D; Thompson F; Davis J; Trent J; Alberts D
    Genes Chromosomes Cancer; 1999 May; 25(1):46-52. PubMed ID: 10221339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.